NanoTox 2018 - Programme

Programme

Plenary speakers

	Chunying Chen, National Center for Nanoscience and Technology of China, Beijing/CN Advanced analytical approaches in understanding biological interactions of nanomaterials
	Shareen H. Doak, Swansea University Medical School/UK In vitro models – the new in vivo?
	John T. Elliott Jr, National Institute of Standards and Technology (NIST), Gaithersburg, MD/USA Statistics and harmonisation - unwanted tools
	Uschi M Graham, University of Kentucky, Lexington, KY/USA *Nanoimaging of Tissue Materials and in situ* Characterization**
	Monique Groenewold, National Institute of Public Health & the Environment (RIVM), Bilthoven/NL Future-proof approaches for NM risk assessment (or what is the information need from regulators and policymakers)
	Thomas Hartung, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD/USA Systems toxicology for nanomaterial safety
	Jörg Kreuter, University of Frankfurt/D History and future perspectives of Nanoparticles as Nanomedical Tools
	Robert Landsiedel, BASF SE, Ludwigshafen/D Results of a Long-term inhalation study with Ceria and Bariumsulphate nanoparticles
	Marion MacFarlane, University of Cambridge/UK *Lessons learned so far - in vivo* analysis of hazard mechanism for Carbon Nanotubes versus Asbestos**
	Bernd Nowack, Empa-Swiss Federal Laboratories for Materials Science and Technology, St. Gallen/CH Predicting nanomaterial flows to the environment: state of the art and new developments
	Homero Fernando Pastrana Rendon, Universidad de los Andes, Bogotá/CO Nanomaterials cytotoxicity assessment by biomechanics and risk management plan for nanomaterials implemented at Universidad de los Andes
	Jonathan Powell, University of Cambridge/UK Nanoparticle uptake by the gut: the endogenous process and hijack by strangers
	Otmar Schmid, Helmholtz Zentrum München, Munich/D Dosimetry: The unsolved mystery in inhalation toxicology
	Adriënne Sips, National Institute of Public Health & the Environment (RIVM), Bilthoven/NL The road to the market: Safer by design and grouping